BioMedPartners
Invests in early- to mid-stage Life Science firms in Switzerland & EU (Germany, Austria, France, Italy, Benelux), focusing on novel drug development, diagnostics, and medtech. Up to CHF 10M per company.
Funding Stage: Series A/B
Investor type: VC Firm
Investment Areas: Biotechnology, Financial Services, Venture Capital, Life Science, Investing
Country: Switzerland
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.